ARCHIVE # 1: 1,457 HEADLINES from 8/2006 to 12/2004
Dr. Timothy L. Vollmer
Chairman, Division of Barrow Neurology

Director, Barrow NeuroImmunology Program

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
My Educational Video on MS and MS Trials
Produced by MD Health Channel
1ST TIME HERE?.....CLICK THE FLASHING RED BUTTON ON THE LEFT!
Visitors Since 03/2006!
Our 841 MySpace Friends
Join us..if you've been affected by MS
THIS COULD SAVE TOUR LIFE!
IF THERE IS A PROBLEM WITH ANY MS DRUG! READ THIS PLEASE: YOU NEED TO CLICK THE RED BUTTON BELOW & GET OUR FREE "MS News Alerts". WE SEND YOU BREAKING NEWS ON ALL MS DRUGS: Scroll down & read what we did last year...within 24 hours of the 1st death from the MS drug Tysabri!
IMPORTANT: We filmed the video below within hours of the 1st death from Tysabri and e-mailed it to everyone who clicked the Flashing Red Button above!...WATCH THE VIDEO...THEN CLICK THE FLASHING RED BUTTON ABOVE!
Timothy L. Vollmer M.D.
Director, Barrow NeuroImmunology Program
Barrow Neurological Institute
St. Joseph's Hospital and Medical Center


BARROW NEUROLOGICAL INSTITUTE'S GRAND CANYON
RIM-RIM-HIKE

Organized by Dr. Spetzler

250 Photo-Slideshow


Click to view 1280 MS Walk photos!

"Join a trial at Barrow & receive all medication & study based procedures at no charge!"
Stan Swartz, CEO, The MD Health Channel

"WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!"
Simply click the "video" buttons below:

.

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

"OUR TEAM IS WORKING ON A CURE FOR MS"
Runtime: 54 sec
Runtime: 54 sec
Susan N. Rhodes
Multiple Sclerosis Research
Barrow Neurological Institute

"'The 2006 Barrow Neurological Institute at St. Joseph's Hospital MS "Walk on the Wild Side" raised more than $460,000 with 3,500 walkers! Click on the blue link above to view photos"

Chris Uithoven
President
National Multiple Sclerosis Society
Arizona Chapter


"THE MS SOCIETY OFFERS MANY PROGRAMS TO HELP...EVERYTHING FROM PILATES & SUPPORT GROUPS TO HORSEBACK RIDING"
Jerry Turner
Program Director
National Multiple Sclerosis Society
Arizona Chapter

Previious Posts

MS NEWS ARCHIVES: by week
12.04  
01.05  
02.05  
03.05  
04.05  
05.05  
06.05  
07.05  
08.05  
09.05  
10.05  
11.05  
12.05  
01.06  
02.06  
03.06  
04.06  
05.06  
08.06  
09.06  
07.13  
04.14  

This page is powered by Blogger. Isn't yours?

January 28, 2005

 

Mylinax targeted to become first oral therapy for multiple sclerosis

January 27, 2005

 

MEMORY PROBLEMS: Alzheimer’s Drug May Help Multiple Sclerosis Patients

 

Australian study helps understanding of Multiple Sclerosis

January 25, 2005

 

Hepatitis B Vaccination Increases Multiple Sclerosis Risk

 

Yoga, Exercise Improve Fatigue Associated With MS

January 21, 2005

     
[FDA NEWS] "First Monoclonal Antibody Treatment For MS Approved"...Tysabri: "First Monoclonal Antibody Treatment For MS Approved"

     

January 20, 2005

 
[Tysabri] FDA NEW RELEASE: FDA has licensed a new biologic approach to treat patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of symptom flare-ups or exacerbations of the disease.FDA has licensed a new biologic approach to treat patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of symptom flare-ups or exacerbations of the disease.

 

January 10, 2005

 

MS PODCAST: PRODUCED BY THE MD HEALTH CHANNEL

"LESSONS I LEARNED ON PICKING THE RIGHT MS DOCTOR".....Andrew Kinney

CLICK TO LISTEN


MP3 File

January 02, 2005

 
FDA Approves Tysabri: "Because of positive data from clinical trials, the FDA approved Tysabri—formerly called Antegren—after only one year of study. Usually, two years of trials are required before approving a new drug.Trial results a 66% reduction in the relapse rate of MS symptoms in patients studied when compared with placebo."

January 01, 2005

 
[Tysabri] Formerly known as Antegren: The Maryland Center for Multiple Sclerosis